Digital Future

Dr. Stephan Aubel

Partner | Rechtsanwalt
Chambers Global 2017
"One of the leading individuals in Capital Markets: Equity"
Chambers Global 2017
"One of the leading individuals in Capital Markets: Equity"
Expertise
Expertise

Stephan’s practice focus is on capital market issues. He has advised numerous companies on their IPOs, capital increases or issuances of bonds. Furthermore he advises clients on corporate law and public M&A.

Vita
After training as a bank clerk Stephan studied at Johann Wolfgang Goethe University in Frankfurt/Main and at the University of Pennsylvania (LL.M. 2002). He has been a partner at Gleiss Lutz since 2007.

Stephan speaks German and English.
Fields
Fields
CorporateCapital MarketsMergers and Acquisitions
Mandates
Mandates
13.01.2021
Gleiss Lutz advises listed company Adler Modemärkte AG in connection with self-administered insolvency
More
21.12.2020
Gleiss Lutz advises Vesync in connection with its IPO on the Hong Kong Stock Exchange
More
16.12.2020
Gleiss Lutz advises Northern Data on capital increase and annual general meeting
More
21.08.2020
Gleiss Lutz advises LEG Immobilien AG in connection with shareholders’ meeting and share dividend
More
11.08.2020
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq
More
Know-How
Know-How
23.03.2020
Virtual general meetings –
changes to the Stock Corporation Act (AktG) due to COVID-19
More
Fields
Fields
CorporateCapital MarketsMergers and Acquisitions
Mandates
Mandates
13.01.2021
Gleiss Lutz advises listed company Adler Modemärkte AG in connection with self-administered insolvency
More
21.12.2020
Gleiss Lutz advises Vesync in connection with its IPO on the Hong Kong Stock Exchange
More
16.12.2020
Gleiss Lutz advises Northern Data on capital increase and annual general meeting
More
21.08.2020
Gleiss Lutz advises LEG Immobilien AG in connection with shareholders’ meeting and share dividend
More
11.08.2020
Gleiss Lutz advises founder and shareholder Dr. Ingmar Hoerr in connection with CureVac’s IPO on the New York stock exchange Nasdaq
More
Um diese Web-App auf Ihrem Homescreen zu speichern, klicken Sie bitte auf „Zum Home-Bildschirm“
Um diese Web-App auf Ihrem Homescreen zu speichern, klicken Sie bitte auf „Zum Startbildschirm zufügen“